These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 35951)

  • 1. Attempts at demonstration of lipopolysaccharide in phase II Coxiella burnetii.
    Schramek S; Brezina R; Kazár J; Khavkin TN
    Acta Virol; 1978 Nov; 22(6):509-11. PubMed ID: 35951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid A component of lipopolysaccharides from Coxiella burnetii.
    Schramek S; Galanos C
    Acta Virol; 1981 Jul; 25(4):230-4. PubMed ID: 6169266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by Coxiella burnetii of ascites tumour formation in mice.
    Kazár J; Schramek S
    Acta Virol; 1979 May; 23(3):267-70. PubMed ID: 41443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of mild acid hydrolysis on the antigenic properties of phase I Coxiella burnetii.
    Schramek S; Brezina R; Kazár J
    Acta Virol; 1978 Jul; 22(4):302-8. PubMed ID: 29469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxiella burnetii phase I and II proteins studied by SDS-page.
    Lukácová M; Kazár J; Gajdosová E
    Acta Virol; 1994 Oct; 38(5):263-7. PubMed ID: 7726000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of splenomegaly in mice by killed Coxiella burnetii cells.
    Kazár J; Schramek S; Zajacová S
    Acta Virol; 1983 Jan; 27(1):65-70. PubMed ID: 6133432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entry of Coxiella burnetii into host cells.
    Baca OG; Klassen DA; Aragon AS
    Acta Virol; 1993; 37(2-3):143-55. PubMed ID: 8105658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different antigenic properties of lipopolysaccharides isolated from Coxiella burnetii in phase I and pure phase II.
    Schramek S; Brezina R; Visacká E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):356-60. PubMed ID: 6417946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of protein and lipopolysaccharide patterns of several Coxiella burnetii strains in phase I.
    Novák M; Brezina R
    Acta Virol; 1989 Mar; 33(2):172-6. PubMed ID: 2569814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved method of isolation of Coxiella burnetii proteins.
    Lukácová M; Kazár J
    Acta Virol; 1996 Feb; 40(1):55-8. PubMed ID: 8886100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an endotoxic lipopolysaccharide from Coxiella burnetii.
    Schramek S; Brezina R
    Acta Virol; 1976 Apr; 20(2):152-8. PubMed ID: 5871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the structural heterogeneity of the polysaccharide component of Coxiella burnetii strain Nine Mile lipopolysaccharide.
    Toman R; Kazár J
    Acta Virol; 1991 Nov; 35(6):531-7. PubMed ID: 1687636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the 3-deoxy-D-manno-2-octulosonic acid region in a lipopolysaccharide isolated from Coxiella burnetii strain Nine Mile in phase II.
    Toman R; Skultéty L
    Acta Virol; 1994 Aug; 38(4):241-3. PubMed ID: 7879717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation by Coxiella burnetii: characterization of a phase I immunosuppressive complex differentially expressed among strains.
    Waag DM; Williams JC
    Immunopharmacol Immunotoxicol; 1988; 10(2):231-60. PubMed ID: 3171107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Coxiella burnetii whole cells and their outer membrane components.
    Gajdosová E; Kovácová E; Toman R; Skultéty L; Lukácová M; Kazár J
    Acta Virol; 1994 Dec; 38(6):339-44. PubMed ID: 7793358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J; Schramek S; Lisák V; Brezina R
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of cloned variants of Coxiella burnetii isolated in China.
    Ning Z; Yu SR; Quan YG; Xue Z
    Acta Virol; 1992 Mar; 36(2):173-83. PubMed ID: 1359769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the determination of "Kdo-like substance" in the lipopolysaccharide from Coxiella burnetii strain nine mile in phase II.
    Toman R; Skultéty L; Kazár J
    Acta Virol; 1993; 37(2-3):196-8. PubMed ID: 8105667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature and linkage type of fatty acids present in lipopolysaccharides of phase I and II Coxiella burnetii.
    Wollenweber HW; Schramek S; Moll H; Rietschel ET
    Arch Microbiol; 1985 Jun; 142(1):6-11. PubMed ID: 4037979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.
    Ftácek P; Skultéty L; Toman R
    J Endotoxin Res; 2000; 6(5):369-76. PubMed ID: 11521057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.